Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
49
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia

Cheng-cheng Liu1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China
,
Hua Wang1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China
,
Wei-da Wang1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China
,
Meng-yuan Zhu1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China
,
Qi-rong Geng1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China
&
Yue Lu1 Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China;3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 3297-3303 | Published online: 12 Nov 2015

References

  • HurdDDVukelichMArthurDC15;17 Translocation in acute promyelocytic leukemiaCancer Genet Cytogenet198263313376956437
  • CastaigneSChomienneCDanielMTAll-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical resultsBlood199076170417092224119
  • WarrellRJFrankelSRMillerWJDifferentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)N Engl J Med1991324138513931850498
  • WangZYChenZAcute promyelocytic leukemia: from highly fatal to highly curableBlood20081112505251518299451
  • ShenZXShiZZFangJAll-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemiaProc Natl Acad Sci U S A20041015328533515044693
  • XinLWan-junSZeng-junLA survival study and prognostic factors analysis on acute promyelocytic leukemia at a single centerLeuk Res20073176577117007927
  • AdesLSanzMAChevretSTreatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsBlood20081111078108417975017
  • CastoldiGLLisoVSpecchiaGTomasiPAcute promyelocytic leukemia: morphological aspectsLeukemia19948Suppl 2S27S327815833
  • SanzMAMartinGDiaz-MediavillaJAll-trans-retinoic acid in acute promyelocytic leukemiaN Engl J Med19983383933949454087
  • AdesLGuerciARaffouxEVery long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceBlood20101151690169620018913
  • QuezadaGKoppLEsteyEWellsRJAll-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemiaPediatr Blood Cancer20085113313518293388
  • Lo-CocoFCicconiLWhat is the standard regimen for patients with acute promyelocytic leukemia?Curr Hematol Malig Rep2014913814324729066
  • Lo-CocoFAvvisatiGVignettiMRetinoic acid and arsenic trioxide for acute promyelocytic leukemiaN Engl J Med201336911112123841729
  • DiverioDPandolfiPPBiondiAAbsence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionBlood199382355635598260693
  • DosSGKatsLPandolfiPPSynergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemiaJ Exp Med20132102793280224344243
  • KakizukaAMillerWJUmesonoKChromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLCell1991666636741652368
  • TallmanMSThe expanding role of arsenic in acute promyelocytic leukemiaSemin Hematol200845S25S2918760708
  • BonatiARizzoliVLunghiPArsenic trioxide in hematological malignancies: the new discovery of an ancient drugCurr Pharm Biotechnol2006739740517168655
  • ChenGQShiXGTangWUse of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cellsBlood199789334533539129041
  • RegoEMPandolfiPPAnalysis of the molecular genetics of acute promyelocytic leukemia in mouse modelsSemin Hematol200138547011172540
  • LoCFAmmatunaENogueraNTreatment of acute promyelocytic leukemia with gemtuzumab ozogamicinClin Adv Hematol Oncol200645762767716562371
  • RaffouxERousselotPPouponJCombined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemiaJ Clin Oncol2003212326233412805334
  • XuSNChenJPLiuJPXiaYArsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysisZhong Xi Yi Jie He Xue Bao200971024103419912733
  • HuJLiuYFWuCFLong-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemiaProc Natl Acad Sci U S A20091063342334719225113
  • SanzMAMontesinosPRayonCRisk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcomeBlood20101155137514620393132
  • ZhouJZhangYLiJSingle-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemiaBlood20101151697170220029047
  • CoutreSEOthusMPowellBArsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapyBr J Haematol201416549750324528179
  • CoombsCCTavakkoliMTallmanMSAcute promyelocytic leukemia: where did we start, where are we now, and the futureBlood Cancer J20155e30425885425

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.